Delivery Order SPE2DB20D2014-SPE2DB25FA95G

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of clonidine hydrochloride extended-release 0.17 mg tablets in 30-count packages. The award is valued at $1,089.14 and has a performance period that extends to July 29, 2024. This contract is a firm fixed-price delivery order awarded under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $4,806.91 firm fixed-price contract is for the provision of clonidine hydrochloride extended-release 0.1 mg tablets. The award is not associated with a set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,640.85, is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract is a firm fixed-price delivery order with a performance period ending on December 15, 2023. This contract award is not designated as a set-aside and appears to be part of a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,912.42, is for the delivery of Clonidine HCL ER 0.1 mg tablets in 60-count packages. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical division. This IDC serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of clonidine HCL ER 0.1 mg tablets in 60-count packages. The $20,024.68 firm fixed-price contract has a completion date of March 12, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, serving as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $3,300.17 firm fixed price contract is for the supply of Clonidine Hydrochloride Extended-Release 0.1 mg tablets in 60-count bottles. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clonidine HCL ER 0.1 mg tablets, with a ceiling value of $9,648.11 and a completion date of December 19, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Clonidine Hydrochloride Extended-Release 0.1 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,027.41, with an ultimate completion date of October 16, 2024. No set-aside designation was used for this award. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,900.30 firm fixed-price delivery order is for the supply of 4562815802 - Clonidine HCL ER 0.1 mg Tablets in 60-count packages. The contract has an ultimate completion date of November 15, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $2,137.63, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets in 60-count packages. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA95G
    Delivery Order

This contract award, with ID SPE2DB20D2014|SPE2DB25FA95G, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of clonidine hydrochloride extended-release 0.1 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,519.08 and a period of performance ending on February 3, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.

Generated 5/2/25, 10:02 AM